Skip to main content

Table 3 Rate of patients with high PeCDF level in each population with three symptoms

From: Cutaneous symptoms such as acneform eruption and pigmentation are closely associated with blood levels of 2,3,4,7,8-penta-chlorodibenzofurans in Yusho patients, using data mining analysis

  Symptom 1 Symptom 2 Symptom 3 Proportion of patients with the symptoms Proportion of patients with high PeCDF (> 50 pg/g lipids)
1 uric acid (high) Sex <female> History of acneform eruptions <present> 0.0755 0.8889
2 History of Yusho in and after 1968 <present> cholesterol (high) Subjective symptoms, etc. <present> 0.0692 0.8485
3 uric acid (high) 1-hour erythrocyte sedimentation rate (elevated) History of acneform eruptions <present> 0.0545 0.8462
4 uric acid (high) 1-hour erythrocyte sedimentation rate (elevated) Sex <female> 0.0650 0.8387
5 Subjective symptoms, etc. <present> Sex <female> History of pigmentation <present> 0.0755 0.8333
6 uric acid (high) Sex <female> History of pigmentation <present> 0.0629 0.8333
7 cholesterol (high) Heaviness of head/headache <present> Subjective symptoms, etc. <present> 0.0503 0.8333
8 History of Yusho in and after 1968 <present> Subjective symptoms, etc. <present> Second quartile age 0.0503 0.8333
9 History of Yusho in and after 1968 <present> uric acid (high) 1-hour erythrocyte sedimentation rate (elevated) 0.0713 0.8235
10 1-hour erythrocyte sedimentation rate (elevated) Subjective symptoms, etc. <present> Sex <female> 0.0713 0.8235